UNSPSC 51293615: Roxindole mesilate

This classification denotes a serotonin agonist and dopamine agonist with the molecular formula C23H26N2O.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WCW8374DTW, chemically known as 1h-indol-5-ol, 3-(4-(3,6-dihydro-4-phenyl-1(2h)-pyridinyl)butyl)-, methanesulfonate (1:1), but more generally known as roxindole mesilate, which bears US NIH Compound Identifier 3035894. European Medicines Agency schedules roxindole mesilate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10399MIG.

Most nations, for tariff purposes, schedule roxindole mesilate under HS 29333999. SMILES: CS(=O)(=O)O.C1CCC(CC1)C2=CCN(CC2)CCCCC3C[NH]C4C3CC(CC4)O.

UNSPSC 51293615 Roxindole mesilate is a Commodity code that does not reflect the pharmaceutical procurement activity currently tagged under it in state and local solicitations. Recent opportunities posted under this code involve naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which are roxindole mesilate or chemically equivalent agents. The mismatch suggests either a tagging error in the underlying procurement systems or that roxindole mesilate itself is not a meaningful driver of state and local procurement volume at present.

The code shows limited decision relevance for vendors seeking state and local pharmaceutical opportunities. Recent activity includes Seminole County, Florida's IFB for naloxone and drug deactivation systems (response deadline July 26, 2023), the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers (due March 26, 2026). Vendors pursuing state and local pharmaceutical supply contracts should monitor higher-level UNSPSC family and class codes rather than this specific commodity code, as the recent opportunities demonstrate that procurement bodies are consolidating purchases through cooperative purchasing vehicles, authorized wholesale networks, and agency-specific health initiatives rather than sourcing individual pharmaceutical compounds by their chemical names.